Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes

This study aims to explore long‐term clinical outcomes of cardiopoiesis‐guided stem cell therapy for ischaemic heart failure assessed in the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial.

[1]  D. K. Arrell,et al.  Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome , 2020, npj Regenerative Medicine.

[2]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.

[3]  D. K. Arrell,et al.  Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy , 2019, Stem Cells Translational Medicine.

[4]  A. Terzic,et al.  Regeneration for All: An Odyssey in Biotherapy. , 2019, European heart journal.

[5]  K. Dickstein,et al.  Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology , 2019, The Lancet.

[6]  R. Bolli,et al.  Potential Strategies for Clinical Translation of Repeated Cell Therapy. , 2019, Circulation research.

[7]  M. Mack,et al.  Transcatheter Mitral‐Valve Repair in Patients with Heart Failure , 2018, The New England journal of medicine.

[8]  A. Terzic,et al.  Clinical Experience With Regenerative Therapy in Heart Failure: Advancing Care With Cardiopoietic Stem Cell Interventions. , 2018, Circulation research.

[9]  P. Menasché.  Cell therapy trials for heart regeneration — lessons learned and future directions , 2018, Nature Reviews Cardiology.

[10]  A. Terzic,et al.  First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery. , 2018, JACC. Cardiovascular interventions.

[11]  A. Terzic,et al.  Posology for Regenerative Therapy. , 2017, Circulation research.

[12]  Robert C. Hendel,et al.  Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study) , 2017, Circulation research.

[13]  J. Hare,et al.  New insights into cell‐based therapy for heart failure from the CHART‐1 study , 2017, European journal of heart failure.

[14]  B. Gersh,et al.  Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) study , 2017, European journal of heart failure.

[15]  Doris A Taylor,et al.  Global position paper on cardiovascular regenerative medicine , 2017, European heart journal.

[16]  A. von Eckardstein,et al.  Safety and efficacy of cardiopoietic stem cells in the treatment of post-infarction left-ventricular dysfunction - From cardioprotection to functional repair in a translational pig infarction model. , 2017, Biomaterials.

[17]  B. Gersh,et al.  Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial , 2016, European heart journal.

[18]  A. Terzic,et al.  Stem cell therapy for heart failure: Ensuring regenerative proficiency. , 2016, Trends in cardiovascular medicine.

[19]  A. Terzic,et al.  CardioPulse: Regenerative medicine in the practice of cardiology. , 2016, European heart journal.

[20]  Judy Ozkan.  CardioPulse: Göran K. Hansson: Sweden's statesman of science. , 2016, European heart journal.

[21]  G. Filippatos,et al.  Clinical development plan for regenerative therapy in heart failure , 2016, European journal of heart failure.

[22]  Phillip C. Yang,et al.  Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease , 2015, Stem cells translational medicine.

[23]  B. Gersh,et al.  Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design , 2015, European journal of heart failure.

[24]  A. Terzic,et al.  Cardiopoietic index predicts heart repair fitness of patient-derived stem cells. , 2015, Biomarkers in medicine.

[25]  E. Braunwald.  The war against heart failure: the Lancet lecture , 2015, The Lancet.

[26]  A. Terzic,et al.  Optimized Delivery System Achieves Enhanced Endomyocardial Stem Cell Retention , 2013, Circulation. Cardiovascular interventions.

[27]  M. Penn,et al.  Stem Cell Therapy for Heart Disease , 2013, Journal of general internal medicine.

[28]  William Wijns,et al.  Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. , 2013, Journal of the American College of Cardiology.

[29]  S. Solomon,et al.  Predictors of Response to Cardiac Resynchronization Therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) , 2011, Circulation.

[30]  A. Terzic,et al.  Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. , 2010, Journal of the American College of Cardiology.

[31]  T. Trikalinos,et al.  Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. , 2010, Journal of the American College of Cardiology.

[32]  D. Schoenfeld,et al.  Combining mortality and longitudinal measures in clinical trials. , 1999, Statistics in medicine.